Xarelto (Rivaroxaban) Tablets

What Is Xarelto (Rivaroxaban)?

Xarelto contains the active ingredient rivaroxaban, an oral anticoagulant that works by selectively blocking Factor Xa, a crucial enzyme in the blood coagulation pathway. By reducing the formation of thrombin, rivaroxaban decreases the likelihood of harmful clot development.

It is widely prescribed across the UK and internationally for the prevention of stroke in certain patients with atrial fibrillation and for the management of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). Clinical guidance from the National Institute for Health and Care Excellence (NICE) and the European Medicines Agency (EMA) supports the use of direct oral anticoagulants such as rivaroxaban in appropriately selected patients.

Therapeutic Uses of Xarelto

• Prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (AF).
• Treatment of deep vein thrombosis (DVT).
• Treatment of pulmonary embolism (PE).
• Prevention of recurrent DVT and PE following initial anticoagulation therapy.
• Prevention of venous thromboembolism after elective hip or knee replacement surgery.
• In selected high cardiovascular risk patients, 2.5 mg twice daily in combination with aspirin, when advised by a prescriber.

Treatment decisions should always align with current clinical guidelines and individual risk assessment.

How Rivaroxaban Works

Blood clot formation involves a complex cascade of enzymatic reactions. Factor Xa plays a central role in converting prothrombin to thrombin, which subsequently leads to fibrin clot formation. Rivaroxaban directly inhibits Factor Xa, interrupting this process.

By limiting thrombin generation, Xarelto helps:

• Reduce stroke risk in atrial fibrillation.
• Treat established DVT or PE.
• Lower the risk of recurrent clot formation.

Available Strengths and Formulations

Xarelto tablets are available in several strengths to accommodate different clinical scenarios:

• 2.5 mg tablets – Often prescribed alongside aspirin for certain cardiovascular indications under specialist supervision.
• 10 mg tablets – Commonly used for VTE prevention following hip or knee replacement surgery.
• 15 mg tablets – Used in specific AF and acute DVT/PE treatment regimens; must be taken with food.
• 20 mg tablets – Frequently prescribed for stroke prevention in AF or continued DVT/PE treatment; must be taken with food.

Dosing and Administration Guidance

Tablet for oral administration.

The precise dose and duration depend on your condition, renal function, age, bleeding risk, and concurrent medicines. Always follow the prescribing clinician’s instructions exactly.

Taking with Food

The 15 mg and 20 mg strengths should be taken with food to ensure optimal absorption. Lower strengths may be taken with or without food as directed.

Missed Dose Advice

If a dose is forgotten, take it as soon as remembered on the same day. Do not take a double dose unless specifically instructed by your prescriber.

Do Not Discontinue Abruptly

Stopping anticoagulation suddenly may increase the risk of thrombotic events. Always consult a healthcare professional before discontinuing therapy.

Side Effects and Safety Information

As with all anticoagulants, the principal risk associated with Xarelto is bleeding.

Commonly Reported Effects

• Increased bruising
• Nosebleeds or bleeding gums
• Prolonged bleeding from minor cuts
• Gastrointestinal discomfort
• Fatigue or weakness, potentially linked to anaemia

Seek Immediate Medical Attention If You Experience:

• Severe or uncontrollable bleeding
• Black or tarry stools
• Red or dark brown urine
• Coughing or vomiting blood
• Sudden severe headache, collapse, or stroke symptoms

Safety guidance is consistent with information published by the Medicines and Healthcare products Regulatory Agency (MHRA) and official product documentation.

Who Should Not Take Xarelto

• Individuals with active clinically significant bleeding.
• Patients with severe hepatic impairment associated with coagulopathy.
• Anyone with hypersensitivity to rivaroxaban or tablet excipients.
• Patients taking strong combined CYP3A4 and P-gp inhibitors or inducers (e.g., ketoconazole, ritonavir, rifampicin) without medical supervision.

Drug, Food and Alcohol Interactions

• Strong CYP3A4 and P-gp inhibitors may increase bleeding risk.
• Strong enzyme inducers may reduce anticoagulant effectiveness.
• Concurrent use with other anticoagulants or antiplatelet agents increases bleeding risk.
• Excessive alcohol consumption may heighten bleeding complications.

Monitoring and Medical Procedures

Routine coagulation monitoring is not generally required with rivaroxaban, unlike warfarin. However, periodic clinical review, renal function assessment, and bleeding risk evaluation are recommended.

Inform all healthcare providers, including dentists and surgeons, that you are taking Xarelto before any invasive procedure.

Pregnancy and Breastfeeding

Rivaroxaban is generally not recommended during pregnancy or breastfeeding unless clearly advised by a specialist. Women of childbearing potential should discuss contraception and risks with their healthcare provider.

Alternative Anticoagulant Options

• Generic rivaroxaban – Contains the same active ingredient as Xarelto and may offer cost savings.
• Eliquis (apixaban) – Another direct Factor Xa inhibitor.
• Dabigatran (Pradaxa) – Direct thrombin inhibitor.
• Edoxaban (Savaysa) – Oral Factor Xa inhibitor.
• Warfarin – Vitamin K antagonist requiring INR monitoring.

Cost-Saving Options

Patients seeking a more affordable supply may consider ordering brand Xarelto or generic rivaroxaban for personal use through LifePath Meds. Orders typically ship as a 90-day supply where appropriate.

View Xarelto and Rivaroxaban pricing options

How to Order Online

1. Select brand Xarelto or generic rivaroxaban in the prescribed strength.
2. Choose a 90-day supply where suitable to optimise value.
3. Complete checkout and await delivery (typically 1–2 weeks).